Fresenius, a global healthcare company, will receive a new €400 million loan from the European Investment Bank (EIB) to strengthen Fresenius’ European research and development (R&D) activities. The financing will be used to support expansion of Fresenius Kabi's manufacturing of medical products and biosimilars in European countries.
The European Investment Bank (EIB) is pleased to announce the appointment of Karl Nehammer as a new Vice-President and Member of its Management Committee, following a decision by the 27 EU Finance Ministers, representing the EIB’s shareholders, the EU Member States.
El Grupo Banco Europeo de Inversiones (Grupo BEI) ha aprobado nueva financiación por un valor total de 15 500 millones de euros para respaldar el crecimiento y la innovación empresarial, mejorar la conectividad energética y del transporte, invertir en vivienda y reforzar la resiliencia hídrica.